Efficacy and Safety of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion Administered as Monotherapy in Patients with Parkinson's Disease

被引：0
|
作者：
Aldred, J.
Henriksen, T.
Bouchard, M.
Martinez-Castrillo, J.
Soileau, M.
Spiegel, A.
Bergmann, L.
Gupta, R.
Kukreja, P.
Standaert, D.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
19
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [31] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study
    Aldred, J.
    Amelin, A.
    Antonini, A.
    Bergmans, B.
    Bergquist, F.
    Bouchard, M.
    Budur, K.
    Carroll, C.
    Chaudhuri, K.
    Criswell, S.
    Danielsen, E.
    Alvarez, E. Freire
    Gandor, F.
    Jia, J.
    Kimber, T.
    Mochizuki, H.
    Robieson, W.
    Spiegel, A.
    Standaert, D.
    Talapala, S.
    Facheris, M.
    Fung, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 178 - 179
  • [32] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
    Jason Aldred
    Eric Freire-Alvarez
    Alexander V. Amelin
    Angelo Antonini
    Bruno Bergmans
    Filip Bergquist
    Manon Bouchard
    Kumar Budur
    Camille Carroll
    K. Ray Chaudhuri
    Susan R. Criswell
    Erik H. Danielsen
    Florin Gandor
    Jia Jia
    Thomas E. Kimber
    Hideki Mochizuki
    Weining Z. Robieson
    Amy M. Spiegel
    David G. Standaert
    Saritha Talapala
    Maurizio F. Facheris
    Victor S. C. Fung
    Neurology and Therapy, 2023, 12 (6) : 1937 - 1958
  • [33] Neutrophil-Rich Infusion Site Reactions After Continuous Subcutaneous Application of Foslevodopa/Foscarbidopa
    Weise, David
    Haferkamp, Sebastian
    MOVEMENT DISORDERS, 2025, 40 (02) : 389 - 390
  • [34] Challenges with Oral Anti-Parkinsonian Medications and Opportunities with Continuous Subcutaneous Infusion (CSCI) Of Foslevodopa/Foscarbidopa (LDP/CDP) for Treatment of Advanced Parkinson's Disease (aPD)
    Aldred, J.
    Soileau, M.
    Yan, C.
    Brion, T.
    Bellenger, A.
    Suh, J.
    O'Donnell, C.
    Kukreja, P.
    Facheris, M.
    Shewale, A.
    Kumar, R.
    MOVEMENT DISORDERS, 2023, 38 : S8 - S9
  • [35] Predictability of Motor States With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson's disease (PD)
    Hauser, R.
    Bouchard, M.
    Santos-Garcia, D.
    Bergmann, L.
    Gupta, R.
    Harmer, L.
    Shah, M.
    Yan, C.
    Isaacson, S.
    MOVEMENT DISORDERS, 2024, 39 : S340 - S341
  • [36] Reply to: "Neutrophil-Rich Infusion Site Reactions after Continuous Subcutaneous Application of Foslevodopa/Foscarbidopa"
    Yoshihara, Nagisa
    Watanabe, Rei
    Nishikawa, Noriko
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2025, 40 (02) : 391 - 392
  • [37] Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial (vol 21, pg 1099, 2022)
    Soileau, M. J.
    Aldread, J.
    Budur, K.
    LANCET NEUROLOGY, 2023, 22 (03) : E5 - E5
  • [38] Continuous subcutaneous apomorphine monotherapy in Parkinson's disease
    Papuc, Ewa
    Trzciniecka, Olga
    Rejdak, Konrad
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (01) : 133 - 137
  • [39] Skin Inflammatory Reactions in Patients with Continuous Subcutaneous Injection of Foslevodopa-Foscarbidopa Hydrate: Histopathology
    Yoshihara, Nagisa
    Nishikawa, Noriko
    Watanabe, Rei
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2025, 40 (02) : 378 - 379
  • [40] Scalable Asymmetric Syntheses of Foslevodopa and Foscarbidopa Drug Substances for the Treatment of Parkinson's Disease
    Huters, Alexander D.
    Stambuli, James
    Klix, Russell C.
    Matulenko, Mark A.
    Chan, Vincent S.
    Simanis, Justin
    Hill, David R.
    Reddy, Rajarathnam E.
    Towne, Timothy B.
    Bellettini, John R.
    Kotecki, Brian J.
    Cardinal-David, Benoit
    Ji, Jianguo
    Voight, Eric A.
    Shou, Minshan
    Balaraman, Selvakumar
    Ashok, Abhishek
    Ghosh, Soma
    JOURNAL OF ORGANIC CHEMISTRY, 2022, 87 (04) : 1986 - 1995
12345